AzTrials
AzTrials

Primary DysmenorrhoeaNCT07771582

Effect of Merged Exercise Versus Relaxation Techniques in Primary Dysmenorrhoea

A study testing Exercise and Relaxation techniques in people with Primary Dysmenorrhoea, run by Cairo University at 1 site in Egypt.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

This study aims to evaluate the effect of aerobic exercises and relaxation techniques on pain severity, quality of life, and menstrual symptoms in females with primary dysmenorrhea. Participants will be randomly assigned to either an exercise and relaxation group or a control group. Read more about this study

Who is it for?
Ages 18 to 25 years, women onlyHealthy volunteers can take part
Conditions the study is for
Primary Dysmenorrhoea
What is being tested?
Exercise and Relaxation techniques
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteEgypt
Study dates
12 Feb 2025to 1 May 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 25 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • All females will be diagnosed as having primary dysmenorrhea
  • All of them are virgin.
  • They have regular menstrual cycle (a menstrual duration of 3-8 days, with 21-35 days between each two successive menstrual cycles).
  • Their age will be ranged from 18 to 25 years old.
  • Their body mass index (BMI) will be ranged from 18 to 25 Kg/m2.

Who cannot join

  • a history of pelvic inflammatory disease.
  • myoma and tumors.
  • pelvic infection,.
  • ovarian cyst.
  • any gynecological disease.
  • any hormonal abnormality.
  • any psychological problem.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of physical therapy Cairo university

    Giza, Giza Government, 12654

Other trials in Egypt

About this study

Official title: Effect of Group of Merged Exercies Versus Relaxation Techniques on Primary Dysmenorrhoea

This study aims to evaluate the effect of aerobic exercises and relaxation techniques on pain severity, quality of life, and menstrual symptoms in females with primary dysmenorrhea.

Participants will be randomly assigned to either an exercise and relaxation group or a control group.

The intervention group will perform aerobic exercises and relaxation sessions for 12 weeks, while the control group will receive no intervention.

Pain levels, quality of life, and menstrual symptoms will be assessed before and after the intervention period.

Being tested
Exercise, Relaxation techniques
Keywords
Exercise, Women, Primary dysmenorrhoea, Relaxation
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ExerciseBehavioural

    A structured exercises program consists of , Adductor stretching ,Bridging exercise, sit up exercises

  • Relaxation techniquesBehavioural

    Astructured relaxation program consisting of Relaxation positure,yoga ,meditation

Study groups in NCT07771582
Study groupRoleWhat they receive
Merged exerciseExperimentalparticipants will receive a structured exercises program consists of hip exercises, ,Bridging exercises ,Cobra pose ,Adductor stretching
Receives: Behavioral: Exercise
Relaxation techniquesActive comparatorParticipants will receive relaxation techniques including Meditation Yoga, Relaxation posture
Receives: Behavioral: Relaxation techniques

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Serum cortisol level at week 12

    Serum cortisol levels will be measured from venous blood samples using a validated laboratory assay and reported in µg/dL (or nmol/L, depending on the laboratory). It will measured at baseline and after 12 weeks of the intervention.

    Measured: Baseline and 8week after the intervention

  2. The Menstrual Distress Questionnaire

    The Menstrual Distress Questionnaire will be used to assess menstrual distress. It assesses 8 factors covered by 47 items. These factors include pain, concentration, behavioral change, autonomic reaction, water retention, negative effect, arousal and control.It is four point rating scale from non as no pain to severe. Maximum score is 141 meaning severe pain and minimum score is 1 meaning very mild pain

    Measured: 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Aug 2026
  2. Study start12 Feb 2025
  3. Primary completion12 May 2025
  4. Study completion1 May 2026

Why it stopped: Recruitment is not achieved

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07771582
Sponsor's protocol ID
P.T.REC/012/006321
Status last verified
Aug 2026
First submitted
14 Jul 2026
Last updated
18 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Exercise and Relaxation techniques in people with Primary Dysmenorrhoea, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 18 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Recruitment is not achieved). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Serum cortisol level at week 12 (time frame: Baseline and 8week after the intervention). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in